Veeva Vault CRM が、イーライリリー・アンド・カンパニーで採用
Source: Prtimes.jp· August 18, 2026
SynaBot summary
Eli Lilly and Company is adopting Veeva Vault CRM, integrating its AI capabilities into their commercial operations. This move signals a significant shift towards AI-driven customer relationship management in the pharmaceutical sector.
Key takeaways
- Eli Lilly adopts Veeva Vault CRM for commercial operations.
- AI features are central to the Veeva CRM implementation.
- This signals increased AI adoption in pharma.
- Expect more specialized AI tools for regulated sectors.
Why it matters
This adoption by a major pharmaceutical company highlights the growing trend of specialized AI tools enhancing efficiency in regulated industries. Professionals using AI assistants can expect more sophisticated, industry-specific solutions for complex workflows.
This story was reported by Prtimes.jp. Read the full original article:
Read on Prtimes.jp 